Chesney, Jason, Igor Puzanov, Frances Collichio, Parminder Singh, Mohammed M. Milhem, John Glaspy, Omid Hamid, et al. 2017. “Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, October, JCO2017737379. http://doi.org/10.1200/JCO.2017.73.7379.